This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
bacteria:t3e:xopay [2023/02/16 14:43] – [Conservation] rkoebnik | bacteria:t3e:xopay [2024/12/16 14:50] (current) – [The Type III Effector XopAY from //Xanthomonas// (replaced by XopAV)] rkoebnik | ||
---|---|---|---|
Line 1: | Line 1: | ||
- | ====== XopAY ====== | + | ====== |
- | Author: [[https:// | + | Author: [[https:// |
- | Internal reviewer: | + | |
- | Expert reviewer | + | |
Class: XopAY\\ | Class: XopAY\\ | ||
Family: XopAY\\ | Family: XopAY\\ | ||
- | Prototype: | + | Prototype: |
- | RefSeq | + | GenBank |
3D structure: Unknown | 3D structure: Unknown | ||
Line 14: | Line 12: | ||
=== How discovered? === | === How discovered? === | ||
+ | |||
+ | XopAY was originally assigned to [[https:// | ||
+ | < | ||
+ | |||
+ | XopAV1 | ||
+ | XCV1197 | ||
+ | XCV1198 | ||
+ | XC_3176 | ||
+ | XopAV2 | ||
+ | |||
+ | XopAV1 | ||
+ | XCV1197 | ||
+ | XCV1198 | ||
+ | XC_3176 | ||
+ | XopAV2 | ||
+ | |||
+ | XopAV1 | ||
+ | XCV1197 | ||
+ | XCV1198 | ||
+ | XC_3176 | ||
+ | XopAV2 | ||
+ | |||
+ | XopAV1 | ||
+ | XCV1197 | ||
+ | XCV1198 | ||
+ | XC_3176 | ||
+ | XopAV2 | ||
+ | |||
+ | XopAV1 | ||
+ | XCV1197 | ||
+ | XCV1198 | ||
+ | XC_3176 | ||
+ | XopAV2 | ||
+ | |||
+ | XopAV1 | ||
+ | XCV1197 | ||
+ | XCV1198 | ||
+ | XC_3176 | ||
+ | XopAV2 | ||
+ | |||
+ | </ | ||
=== (Experimental) evidence for being a T3E === | === (Experimental) evidence for being a T3E === | ||
+ | The promoter and signal region of XC_3176 were fused to the HR-inducing AvrBs1 C-terminal domain lack of 58 N-terminal amino acid residues. This construct elicited an hypersensitive response on the pepper ECW-10R containing the corresponding resistance gene //Bs1// in a // | ||
=== Regulation === | === Regulation === | ||
+ | A reporter GUS fusion of XC_3176 displayed GUS activities, which were significantly lower in the mutant strains Δ//hrpX// and Δ//hrpG// than that in the wild type //X. campestris// | ||
=== Phenotypes === | === Phenotypes === | ||
+ | XC_3176 was found to be required for the full virulence of //X. campestris// | ||
=== Localization === | === Localization === | ||
+ | |||
+ | Unknown | ||
=== Enzymatic function === | === Enzymatic function === | ||
- | Predicted peptidylprolyl isomerase. | + | Unknown |
=== Interaction partners === | === Interaction partners === | ||
+ | |||
+ | Unknown | ||
===== Conservation ===== | ===== Conservation ===== | ||
Line 33: | Line 79: | ||
=== In xanthomonads === | === In xanthomonads === | ||
- | Universally conserved protein. | + | Yes (e.g. //X. campestris//, |
=== In other plant pathogens/ | === In other plant pathogens/ | ||
- | Universally conserved protein. | + | No |
===== References ===== | ===== References ===== | ||
- | Kara S (2016). | + | Teper D, Burstein D, Salomon D, Gershovitz M, Pupko T, Sessa G (2016). |
- | Kara S, Timilsina S, Jacques MA, Potnis N, Vallad G, Fischer-Le Saux M, Hurlbert JC, Minsavage GV, Jones JB (2017). A novel type III Xop effector in // | + | Yang L, Su H, Yang F, Jian H, Zhou M, Jiang W, Jiang B (2015). Identification of a new type III effector |